Pacific Biosciences of California Inc. buy The Goldman Sachs Group, Inc.
Start price
10.04.24
/
50%
€3.26
Target price
10.04.25
€6.50
Performance (%)
-43.55%
Price
11:56
€1.84
Summary
This prediction is currently active. Massive losses of -43.55% have been the result for the BUY prediction by The_Goldman_Sachs_Gr. This prediction currently runs until 10.04.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacific Biosciences of California Inc. | 0.312% | 0.312% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $9.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for PACB provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€12.81
30.06.23
30.06.23
€15.60
30.06.24
30.06.24
-85.63%
11:56
11:56